Birchview Capital as of June 30, 2018
Portfolio Holdings for Birchview Capital
Birchview Capital holds 53 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 37.0 | $55M | 686k | 79.42 | |
| Accelr8 Technology | 33.1 | $49M | 2.2M | 22.30 | |
| Neurocrine Biosciences (NBIX) | 3.3 | $4.9M | 50k | 98.24 | |
| Contrafect | 1.6 | $2.4M | 1.1M | 2.21 | |
| Quidel Corporation | 1.5 | $2.3M | 34k | 66.49 | |
| Array BioPharma | 1.5 | $2.1M | 128k | 16.78 | |
| Encana Corp | 1.4 | $2.1M | 162k | 13.05 | |
| EQT Corporation (EQT) | 1.4 | $2.1M | 38k | 55.17 | |
| Oxford Immunotec Global | 1.4 | $2.0M | 157k | 12.89 | |
| Vermillion | 1.2 | $1.7M | 2.2M | 0.78 | |
| Vanda Pharmaceuticals (VNDA) | 1.1 | $1.7M | 88k | 19.05 | |
| Soleno Therapeutics | 1.1 | $1.6M | 678k | 2.34 | |
| Albireo Pharma | 0.9 | $1.3M | 38k | 35.50 | |
| Atara Biotherapeutics (ATRA) | 0.8 | $1.2M | 34k | 36.76 | |
| Sientra | 0.8 | $1.2M | 63k | 19.51 | |
| Arena Pharmaceuticals | 0.7 | $1.1M | 25k | 43.60 | |
| G1 Therapeutics (GTHX) | 0.7 | $956k | 22k | 43.45 | |
| Veracyte (VCYT) | 0.6 | $923k | 99k | 9.34 | |
| Clementia | 0.6 | $895k | 68k | 13.16 | |
| Karyopharm Therapeutics (KPTI) | 0.6 | $850k | 50k | 17.00 | |
| Wright Medical | 0.5 | $779k | 30k | 25.97 | |
| Masimo Corporation (MASI) | 0.5 | $781k | 8.0k | 97.62 | |
| Corcept Therapeutics Incorporated (CORT) | 0.5 | $786k | 50k | 15.72 | |
| Voyager Therapeutics (VYGR) | 0.4 | $645k | 33k | 19.55 | |
| Axogen (AXGN) | 0.4 | $603k | 12k | 50.25 | |
| Acceleron Pharma | 0.4 | $582k | 12k | 48.50 | |
| Biogen Idec (BIIB) | 0.4 | $580k | 2.0k | 290.00 | |
| Pioneer Natural Resources (PXD) | 0.4 | $568k | 3.0k | 189.33 | |
| Dicerna Pharmaceuticals | 0.4 | $551k | 45k | 12.24 | |
| Amicus Therapeutics (FOLD) | 0.4 | $531k | 34k | 15.62 | |
| Inflarx Nv (IFRX) | 0.3 | $516k | 16k | 32.25 | |
| Nektar Therapeutics (NKTR) | 0.3 | $464k | 9.5k | 48.84 | |
| Xencor (XNCR) | 0.3 | $455k | 12k | 36.99 | |
| Imprimis Pharmaceuticals | 0.3 | $396k | 180k | 2.20 | |
| Yield10 Bioscience | 0.3 | $382k | 271k | 1.41 | |
| Myriad Genetics (MYGN) | 0.2 | $374k | 10k | 37.40 | |
| Tesaro | 0.2 | $365k | 8.2k | 44.51 | |
| Intercept Pharmaceuticals In | 0.2 | $361k | 4.3k | 83.95 | |
| Sito Mobile (STTO) | 0.2 | $363k | 140k | 2.59 | |
| Aptinyx | 0.2 | $242k | 10k | 24.20 | |
| AVEO Pharmaceuticals | 0.1 | $226k | 100k | 2.26 | |
| Clovis Oncology | 0.1 | $227k | 5.0k | 45.40 | |
| Oncomed Pharmaceuticals | 0.1 | $228k | 99k | 2.31 | |
| Solid Biosciences | 0.1 | $214k | 6.0k | 35.67 | |
| Tg Therapeutics (TGTX) | 0.1 | $197k | 15k | 13.13 | |
| Ironwood Pharmaceuticals Inc dbcv 2.250% 6/1 | 0.1 | $191k | 10k | 19.10 | |
| Biolase Technology | 0.1 | $165k | 136k | 1.21 | |
| Genocea Biosciences | 0.1 | $163k | 189k | 0.86 | |
| Aevi Genomic | 0.1 | $142k | 128k | 1.11 | |
| Endocyte | 0.1 | $138k | 10k | 13.80 | |
| Celgene Corp right 12/31/2011 | 0.1 | $99k | 242k | 0.41 | |
| Cytokinetics (CYTK) | 0.1 | $83k | 10k | 8.30 | |
| Workhorse Group Inc ordinary shares (WKHS) | 0.0 | $46k | 25k | 1.84 |
